Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Samer Tabchi

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Le Journal Medical Libanais. the Lebanese Medical Journal|November 20, 2018
EARLY INCREASE of CA 19-9 in ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX. Is it a sign of efficacy?Samer Tabchi, Hampig R Kourie, Fadi Farhat, et al.
Future Oncology (London, England)|January 11, 2018
Ramucirumab in HER-2-positive gastroesophageal adenocarcinoma: an argument for overcoming trastuzumab resistanceMustapha Tehfe, Samer Tabchi, Maria Maddalena Laterza, et al.
The Gulf Journal of Oncology|February 14, 2017
Unusual Destruction of the Nasal SeptumTarek Assi, Elie El Rassy, Tania Moussa, et al.
Leukemia Research Reports|August 13, 2015
Pseudo-Guillain-Barré syndrome masking acute myeloid leukemia relapse: Brief report and reviewFadi El Karak, Elie El Rassy, Samer Tabchi, et al.
Clinics and Research in Hepatology and Gastroenterology|November 14, 2015
Pancreatic small cell cancerElie El Rassy, Samer Tabchi, Hampig Raphael Kourie, et al.
International Journal of Clinical and Experimental Pathology|June 6, 2015
BRAFV600 mutant non-small-cell lung cancer resistant to VemurafenibFadi El Karak, Tarek Assi, Hampig Raphael Kourie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 3, 2015
Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximabElie El Rassy, Samer Tabchi, Fady G Haddad, et al.
Seminars in Oncology|December 18, 2017
Management of stage III non-small cell lung cancerSamer Tabchi, Elie Kassouf, Elie El Rassy, et al.
Journal of Cancer Research and Therapeutics|September 11, 2018
Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experienceTarek Assi, Joseph Kattan, Elie El Rassy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 23, 2015
Treatment of cancer patients in their last month of life: aimless chemotherapyTarek Assi, Elie El Rassy, Samer Tabchi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Le Journal Medical Libanais. the Lebanese Medical Journal|November 20, 2018
EARLY INCREASE of CA 19-9 in ADVANCED PANCREATIC CANCER RECEIVING FOLFIRINOX. Is it a sign of efficacy?Samer Tabchi, Hampig R Kourie, Fadi Farhat, et al.
Future Oncology (London, England)|January 11, 2018
Ramucirumab in HER-2-positive gastroesophageal adenocarcinoma: an argument for overcoming trastuzumab resistanceMustapha Tehfe, Samer Tabchi, Maria Maddalena Laterza, et al.
The Gulf Journal of Oncology|February 14, 2017
Unusual Destruction of the Nasal SeptumTarek Assi, Elie El Rassy, Tania Moussa, et al.
Leukemia Research Reports|August 13, 2015
Pseudo-Guillain-Barré syndrome masking acute myeloid leukemia relapse: Brief report and reviewFadi El Karak, Elie El Rassy, Samer Tabchi, et al.
Clinics and Research in Hepatology and Gastroenterology|November 14, 2015
Pancreatic small cell cancerElie El Rassy, Samer Tabchi, Hampig Raphael Kourie, et al.
International Journal of Clinical and Experimental Pathology|June 6, 2015
BRAFV600 mutant non-small-cell lung cancer resistant to VemurafenibFadi El Karak, Tarek Assi, Hampig Raphael Kourie, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 3, 2015
Acquired factor inhibitor in a patient with monoclonal gammopathy of undetermined significance responding to rituximabElie El Rassy, Samer Tabchi, Fady G Haddad, et al.
Seminars in Oncology|December 18, 2017
Management of stage III non-small cell lung cancerSamer Tabchi, Elie Kassouf, Elie El Rassy, et al.
Journal of Cancer Research and Therapeutics|September 11, 2018
Efficacy and safety of everolimus in hormone receptor positive breast cancer in a developing country: Real-life single institutional experienceTarek Assi, Joseph Kattan, Elie El Rassy, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|September 23, 2015
Treatment of cancer patients in their last month of life: aimless chemotherapyTarek Assi, Elie El Rassy, Samer Tabchi, et al.
Pageof 3